tiprankstipranks
Enfusion (ENFN)
NYSE:ENFN
US Market

Enfusion (ENFN) Income Statement

Compare
35 Followers

Enfusion Income Statement

Last quarter (Q3 2024), Enfusion's total revenue was $51.17M, an increase of 15.35% from the same quarter last year. In Q3, Enfusion's net income was $1.42M. See Enfusion’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 174.53M$ 150.35M$ 111.70M$ 79.56M$ 59.03M
Gross Profit
$ 116.89M$ 103.25M$ 79.86M$ 58.21M$ 42.07M
Operating Expenses
$ 104.95M$ 115.21M$ 355.74M$ 52.13M$ 28.20M
Depreciation and Amortization
$ 9.99M$ 6.60M$ 3.98M$ 2.29M$ 1.16M
EBITDA
$ 21.93M$ -5.62M$ -271.91M$ 8.37M$ 15.02M
Operating Income
$ 11.95M$ -11.96M$ -275.88M$ 6.07M$ 13.87M
Other Income/Expenses
$ -464.00K$ -225.00K$ -5.78M$ -1.58M$ -727.00K
Pretax Income
$ 11.48M$ -12.19M$ -281.66M$ 4.49M$ 13.14M
Net Income
$ 6.03M$ -13.26M$ -282.24M$ 4.06M$ 12.66M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.10$ -0.16$ -4.30$ 0.04$ 0.11
Diluted EPS
$ 0.07$ -0.16$ -4.30$ 0.04$ 0.11
Weighted Average Shares Outstanding
88.20M 85.39M 65.58M 113.05M 113.05M
Weighted Average Shares Outstanding (Diluted)
129.43M 85.39M 65.58M 113.05M 113.05M
Currency in USD

Enfusion Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis